ETROLIZUMAB VERSUS INFLIXIMAB FOR TREATING PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 GARDENIA STUDY

Silvio Danese  ¹     Jean-Frederic Colombel  ²     Milan Lukas  ³     Javier Gisbert  ⁴     Geert R. D'Haens  ⁵     Bu Hayee  ⁶     Remo Pannacione  ⁷     Hyun-Soo Kim     Walter Reinisch     Helen Tyrrell     Young Oh     Swati Tole     Akiko Chai     Kirsten Chamberlain-James     Meina Tao Tang     Stefan Schreiber    
¹ Humanitas University,Milan,Italy
² Icahn School of Medicine at Mount Sinai,New York,United States
³ Charles University,Prague,Czech Republic
⁴ La Princesa University Hospital, IIS-IP and CIBEREHED,Madrid,Spain
⁵ Amsterdam University Medical Center,Amsterdam,Netherlands
⁶ Kings College London,London,United Kingdom
⁷ University of Calgary,Ca

Session
UEG Research Prize 2020 Session

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)